CEO Dr. Steve Cutler commented, "ICON continues to navigate dynamic clinical development market conditions, as trial activity has been impacted by cautious spending from biopharma customers ...
Another way to ensure you're reading and editing large spreadsheets accurately is using Excel's Freeze Panes tool, which keeps certain rows and columns on screen when you scroll down and across. Using ...
ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research organization said that it expects to report 2025 revenue of $8.05B to $8.650B ...